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PARAMETER MERAMALKAN SEPSIS KLINIKAL DALAM NEONAT  
ABSTRAK 
 
Pengenalan: 
Sepsis neonatal merupakan masalah kesihatan utama di seluruh dunia. Pentakrifan 
tentang sepsis masih kekal sebagai satu isu yang amat sukar. Kajian ini bertujuan untuk 
menentukan parameter yang paling berguna untuk meramal sepsis yang disahkan atau 
sepsis klinikal. 
 Kaedah: 
Ini adalah kajian keratan rentas yang dijalankan di wad rawatan tapi bayi( NICU) di 
Hospital USM dan Hospital Raja Perempuan Zainab II( HRPZ II) antara Julai 2012 dan 
Julai 2013 yang melibatkan semua bayi baru lahir  yang diberi rawatan antibiotik. Satu  
pelekat khas dan folder bayi yang terlibat dengan kajian ini akan disemak semula bagi 
setiap episod jangkitan yang disyaki. 
Berdasarkan keputusan  kultur darah dan tempoh antibiotik bang di peskripsi bayi 
dibahagikan kepada: sepsis disahkan, sepsis klinikal dan bukan sepsis. Tiga puluh empat 
parameter berkaitan sepsis telah diperiksa untuk meneliti perkaitan mereka dengan 
kultur darah yang positif dalam setiap kumpulan menggunakan khi-kuasa dua dan ujian 
tepat Fisher. Kepekaan dan kekhususan parameter individu ditentukan menggunakan 
jadual 2x2 dan bagi model ramalan penentuaanya ditentukan dengan  menggunakan 
perisian Stata.  
 
xvi 
 
 
 
Keputusan: 
Sejumlah 1514 episod  yang disyaki sepsis dari 1325 bayi telah dimasukkan kedalam 
kajian ini. Nisbah lelaki kepada perempuan adalah 1:1.3. Sebanyak enam puluh empat 
peratus  bayi yang matang terlibat dalam kajian ini dan lebihnya 36% adalah bayi 
pramatang. Kebanyakan bayi  (61%) mempunyai berat badan >2500g. LBW (1500-
2500g), VLBW (<1500g) dan ELBW (<1000) dicatatkan sebanyak 31.4%,6.2% dan 
1.1% secara berturut. 
Diantara 1514 episod yang disyaki sepsis, sebanyak 51 (3.4%) disahkan sepsis, 
612(4.04%) sebagai kinikal sepsis dan 851 (56.2%) bukan sepsis. Didapati 69% EOS 
dan LOS pula 31%.  Bakteria gram negative mewakili majority patogen yang di isolat  
(60%). 
Enambelas daripada 34 parameter mempunyai perkaitan statistik secara signifikan 
dengan yang disah sepsis dan  21 dengan disah sepsis dan sepsis klinikal,  mereka ini 
diletakkan sebagai satu kumpulan. Apnoea, PCRT, kelesuan ,CRP meningkat dan 
thrombositopenia menunjukkan perkaitan positif yang paling kuat (0.001), diikuti 
dengan sawan, disyaki NEC dan leukopenia (p= 0.001). Hanya PROM > 12h 
menunjukkan perkaitan yang negatif.   
Antara parameter individu yang cukup sensitif untuk mendiagnos dengan tepat 
permulaan disah sepsis yang lambat: sensitiviti yang paling tinggi dilihat berkait dengan 
pramatang  adalah 64%. Sensitiviti model yang dibuat dengan 2 parameter signifikan 
xvii 
 
mempunyai ketepatan yang paling tinggi dengan kesensitifan sebanyak 61.3%, 
kekhususan 93.6% dan AUC 0.85%. 
Kesimpulan: 
Apnoe, PCRT, kelesuan , CRP meningkat dan trombositopenia merupakan parameter 
dalam kajian ini yang menunjukkan perkaitan positif yang paling kuat ( p<0.001) dengan 
bayi disahkan sepsis. Namun begitu, ia jelas menunjukkan bahawa diagnosis sepsis 
adalah sesuatu yang kompleks, dan tiada satu parameter atau kombinasi parameter yang 
boleh meramal dengan tepat kepositifan  kultur.  
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                PARAMETERS PREDICTING CLINICAL SEPSIS IN NEONATES 
ABSTRACT 
 
Introduction: 
Neonatal sepsis is a major health problem worldwide. The definition of sepsis remains 
an extremely difficult issue. This study aimed to determine the most useful parameters to 
predict confirmed sepsis or clinical sepsis.   
Methods:   
This was a cross sectional study conducted in NICUs at Hospital USM and HRPZ II 
between July 2012 and July 2013 involving all newborns who were started on 
antibiotics. A special sticker and the folders of enrolled neonates were reviewed for each 
episode of suspected infection.   
Based on blood culture results and duration of antibiotics, babies were divided into: 
confirmed sepsis, clinical sepsis and no sepsis. Thirty four sepsis related parameters 
were checked for their association with positive blood cultures in each group using Chi-
square and Fisher’s exact tests. The sensitivity and specificity of individual parameters 
were determined using 2x2 tables and for the predictive model were determined using 
Stata software.   
 
Results:  
A total of 1514 episodes of suspected sepsis in 1325 neonates were included in the 
study. Male to female ratio was 1:1.3. Sixty four percent of involved babies were term, 
xix 
 
while 36% were preterm. The majority (61%) had a birth weight of >2500g. LBW 
(1500-2500g), VLBW (<1500g) and ELBW (<1000) were recorded in 31.4%, 6.2% and 
1.1% respectively. 
Out of 1514 episodes of suspected sepsis, confirmed sepsis was found in 51(3.4%), 
clinical sepsis in 612 (40.4%) and no sepsis in 851(56.2%). EOS and LOS were found in 
69% and 31% respectively. Gram negative bacteria represented the majority of isolated 
pathogens (60%). 
Sixteen out of 34 parameters were statistically significantly associated with confirmed 
sepsis and 21 with confirmed and clinical sepsis, considered as one group.  Apnoea, 
PCRT, lethargy, raised CRP and thrombocytopenia were showed the strongest positive 
association (p<0.001), followed by convulsions, suspected NEC and leukopenia (p= 
0.001).Only PROM>12 h was showed a negative association. 
 None of individual parameters were sensitive enough to accurately diagnose the late 
onset confirmed sepsis: the highest sensitivity 64.0%, seen with prematurity. The 
sensitivity of the model made from at least 2 significant parameters had the highest 
accuracy with sensitivity 61.3%, specificity 93.6% and AUC of 0.85. 
Conclusion:  
 Apnoea, PCRT, lethargy, raised CRP and thrombocytopenia were the parameters in this 
study that showed the strongest positive association (p<0.001) with confirmed neonatal 
sepsis. However it remains clear that the diagnosis of sepsis is a complex one, and no 
single parameter or combination of parameters can accurately predict culture positivity. 
xx 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background 
Many terms, including “neonatal sepsis”, “neonatal septicaemia” and “sepsis 
neonatorum” are generally used to describe the infant’s systemic response to infection 
within the first 30 days of life, which requires the presence of both physical and 
supportive laboratory findings for its diagnosis. 
The role of a positive blood culture has been that of a golden standard for diagnosis with 
the exception of blood cultures positive with common skin flora or non-virulent 
organisms. The Centres for Disease Control and prevention and National Healthcare 
Safety Network CDC/NHSN have come out with two criteria to define the laboratory 
confirmed blood stream infection (LCBI) which are:  
(1) isolation of a recognized organism from one or more blood cultures plus either the 
presence of at least one suggestive sign or symptom or positive laboratory result  
(2) presence of suggestive signs and symptoms of sepsis and isolation of common skin 
contaminant cultured from 2 or more blood cultures drawn on separate occasions  
(Horan and MPH, 2008). 
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There may be a lot of reasons however for the blood culture to be negative even in 
infected babies. Among these are: 
- The low predictability of blood culture if intra-partum antibiotics had been given to the 
mother 
- Postnatal blood cultures might fail to detect bacteraemia in a significant number of 
cases when the bacteraemia is transient or intermittent  
- Blood cultures may be falsely negative when an insufficient amount of blood has been 
obtained for culture, and /or processing of the sample and the culture process are sub-
optimal. 
 
 Because of this and because babies with infection who are not or only partially treated 
can deteriorate very fast, several authors (Chiesa et al., 2004; Sankar et al., 2008) 
believed that the sepsis (clinical sepsis) should be considered if there is any systemic 
response to infection even in the absence of evidence of bacteraemia or clear focus of 
infection. Most clinicians tend to consider the infant is having sepsis based on risk 
factors, clinical signs and laboratory parameters (haematological and acute phase 
proteins) rather than on the blood culture result alone (Sivanandan et al., 2011) 
Until now, neonatologists have not achieved any standardized definition for neonatal 
blood stream infection (BSI), which is perhaps mostly due to the insensitivity of blood 
culture tests in the neonates, the variable presentations of sepsis in neonates and the lack 
of sensitive and specific laboratory diagnostic tests as well as the discrepancies among 
the tests (Haque, 2005). Therefore, researchers in this field were pushed to create their 
own definitions to outfit the aim of their own particular studies. These definitions had to 
3 
 
be clear with regard to type of studied infant (defined by gestational age and birth 
weight), baby’s age, culture results, clinical condition, and severity of the illness (Chiesa 
et al., 2004)  
Fleming et al, affirmed that the inclusion of clinical criteria in the definition of 
bacteraemia helped to improve the evaluation of early onset neonatal sepsis (Fleming et 
al., 2012).For babies who are thought to have culture negative sepsis, the term clinical 
sepsis has been used widely and this will be the term used in the rest of this thesis as 
well. A large variety of clinical manifestations are deemed to be important to be part of 
the definitions of clinical sepsis. Haque (Haque, 2005) suggested the clinical features of 
respiratory distress, temperature instability, and prolonged capillary refill time in 
addition to the suggestive laboratory tests as abnormality of white blood cell (WBC) 
count and raised C-reactive protein (CRP).  
 
CRP is however a late marker and the search for early and more sensitive and specific 
markers of infection has been quite extensive. Efforts have included proteins such as 
procalcitonin, several interleukins and cytokines and detection of bacterial antigens in 
the blood. Most of these newer diagnostic methods have been not become widely 
available for clinical use in middle and low income countries because they were either 
too expensive or still in an experimental stage. 
  
This study was conducted to determine which of the easily available clinical and 
laboratory parameters that make the clinicians suspect infections in the neonate are most 
commonly associated with culture positive infection and with clinical sepsis as 
4 
 
determined by the neonatologist. It was hoped that this study could help in making the 
definition of clinical sepsis for the clinician working in the setting of middle or low 
income countries a bit easier. 
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1.2 LITERATURE REVIEW  
1.2.1 Neonatal infection and mortality 
According to a World Health Organization (WHO) Report, the global neonatal 
mortality rate is 28 per 1,000 live births with a great variation between regions, being 
highest in Africa with 40/1,000 and lowest in Europe 10/1,000. A wide variation is 
evident between different countries: - while it is only 1/1,000 in Iceland and Singapore, 
while, in Liberia it is up to 66/1,000 (Geneva, 2010).  
The huge majority of all neonatal deaths occur in low- or middle-income countries with 
a neonatal mortality rate range from 41/1000 and 27/1000 -in low-income regions and 
lower-middle income, respectively, compared to 4/1000 in high-income regions (Lawn 
et al., 2005).  
 
About 25 to 50% of neonatal deaths occur in the first 24 h while 75% within the first 
week. Sixty to eighty percent of neonatal deaths arise in low birth weight infants (< 2500 
g). It has been found that, the neonatal mortality reduced by 30 – 50% with an increase 
in the mean birth weight by 100g (Bizzarro et al., 2005). 
 
Globally, infections, prematurity and asphyxia are the major leading causes of neonatal 
death while congenital malformations account for of the remaining (Qazi and Stoll, 
2009; Black et al., 2010; Liu et al., 2014). More than 1 million newborns die of 
infections each year. Most of these occur in the late neonatal period. However, in high-
6 
 
resources countries, infections have a less important role. Instead, congenital 
malformations becoming the most significant cause of neonatal death (Saugstad, 2010). 
 
The mortality rate, in a study from 8 Asian neonatal intensive care units (NICUs), was 
13% for early onset sepsis and 8.9% for late onset. While, the overall mortality (as a 
direct outcome for sepsis) was stated as 0.69 deaths /1000 live births (Tiskumara et al., 
2009). 
 
1.2.2 Incidence of neonatal infection 
Generally, the incidence of serious bacterial sepsis in developed countries is 1–
4/1000 live births and 2–21/1000 live births in developing and low-income countries. 
The incidence of infection and sepsis in pre-term infants is 3–10 fold greater than that in 
full-term infants of normal birth weight (Yeung and Davies,2005). 
 
A study by Tiskumara by analysing data from eight NICUs in seven countries in Asia 
(two from China and one each from Hong Kong, India, Kuwait, Iran, Malaysia and 
Thailand) stated that, the overall figure of sepsis was 11.6 per 1000 live births, with the 
rates varying between 2 per 1000 live births in Hong Kong up to 22 per 1000 live births 
in Thailand. The overall rate of a baby having either early or late sepsis in the same 
study varied from 3.0 per 1000 live births in Hong Kong to 15.0 per 1000 live births in 
Kuwait (Tiskumara et al., 2009). 
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A study done over 3 years in England found that the incidence of early onset sepsis 
(EOS) was similar over the whole period of the surveillance and it was 0.9 per 1000 live 
births and 9 per 1000 neonatal admissions .The overall incidence of late onset sepsis 
(LOS) was 3/1000 live births and 29/1000 neonatal admissions and it was similar in 
each of the years of surveillance (Vergnano et al., 2011). The overall incidence of 
nosocomial infection in a six-year surveillance study done in Spain was 25.6% per 
admission (Molina-Cabrillana et al., 2006). 
 
A significant discrepancy was noted between the incidence of proven and clinical sepsis.  
Clinical sepsis found to be more common than culture confirmed sepsis in a study done 
in Korea. The estimated incidence rate of neonatal sepsis during the study period was 
30.5 per 1000 live births for clinical sepsis whereas for sepsis with positive culture, it 
was only 6.1 per 1000 live births (Shin et al., 2009). 
The rate of clinical sepsis in developing countries was reported to be ranging from 49 to 
170 per 1000 live births in population based studies (Thaver and Zaidi, 2009). Other 
studies have found that the average incidence of culture confirmed sepsis in these 
countries was only 16 per 1000 live births.  This was consistent with a result from 
Bangladesh in a recent population-based surveillance study: the incidence rate of 
clinically suspected neonatal sepsis was found to be 50 per 1000 live births, and the 
incidence of culture confirmed sepsis was 3 per 1000 live births  (Ganatra and Zaidi, 
2010) 
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A recent review of 5 studies reporting the incidence of early onset sepsis in developing 
countries found that, the incidence of culture confirmed EOS was ranging from 2.2 - 9.8 
per 1000 live births, while the incidence of clinical sepsis was ranging from 20.7 to 50 
per 1000 live births (Mehmet Satar, 2012). 
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1.2.3 Classification of neonatal sepsis  
1.2.3.1 According to the onset of sepsis 
Neonatal sepsis is usually categorized as early onset or late onset sepsis 
depending upon the onset of symptoms and signs of the sepsis. So far, the exact cut-off 
points in time used to define early and late have been the subject of controversy. 
Classically, if symptoms appear before 48-72 hours after birth the sepsis is considered 
early onset sepsis (EOS); if later than that it is a late onset sepsis (LOS). However, some 
investigators as (Seale et al., 2009; Mukhopadhyay and Puopolo, 2012; Mayor-Lynn et 
al., 2005) considered infection occurring in the first 7 days of life as EOS.  
 For the purpose of this study the cut-off point between early and late onset sepsis was 
taken as 48 hours. 
 
The classification between early and late onset sepsis has contributed greatly to a better 
diagnosis and treatment by identifying which microorganisms are likely to be 
responsible for sepsis during these periods. 
 
1.2.3.1(A) Early Onset Sepsis (EOS) 
Early onset sepsis is an infection that occurs within the first 48 to 72 hours of life 
and the microorganisms are generally acquired from the mother while passing through a 
colonized birth canal at delivery (Bhutta and Yusuf, 1997; Chacko and Sohi, 2005) 
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In a study that considered a cut-off point at 72 hours after birth, the majority of new-
borns (85%) with EOS presented within the first 24 hours, 5% presented at 24-48 hours. 
while 10% presented between 48-72 hours. Onset was much more rapid in premature 
neonates (Anderson-Berry et al., 2006). 
 Infants with EOS present frequently with pneumonia or enterocolitis and less frequently 
with meningitis and septicaemia (Hasanov, 2010).  
 
A study by Mukhopadhyay and Puopolo, found that the incidence of EOS among very 
low birth infants (VLBW) was 15-19 per 1000 live births, and had remained stable 
despite a change in the causative pathogens over the time. This was in contrast with the 
overall incidence which had dramatically declined with the advances in obstetrical and 
neonatal care. 
This was more evident for GBS-specific EOS after using the guideline recommendations 
of intra-partum antibiotic prophylaxis (IAP) to prevent perinatal group B Streptococcus 
(GBS) disease. The incidence had decreased from 3-4 cases/ 1000 live births to 0.3-0.4 
cases/ 1000 live births (Mukhopadhyay and Puopolo, 2012).  
 
A surveillance done by Hyde (Hyde et al., 2002) involved 408 infants aged  less than7 
days who were identified as having early-onset sepsis during a 3- year study period 
(1998 to 2000). It was found that the rate of antibiotic-resistant E coli infections had 
increased among preterm infants during the study period. While other pathogens, 
including GBS were low and did not change significantly. However, an analysis of 
trends in GBS and E. coli related early onset sepsis from longitudinal prospective 
surveillance done in Australia and in New Zealand during a 10-year period from 1992 
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through 2001 by Daley and Isaacs showed that, the use of intra-partum antibiotics was 
associated with a steady decline in GBS early onset sepsis in Australasia, as well as E. 
coli early onset sepsis in all babies.(Daley et al., 2004)  
  
In a study done in Asia, it was found that the rate of EOS from any pathogen was 0.72 
infections/1000 live births and EOS constituted about 10.4% of all infections reported 
(Tiskumara et al., 2009) . 
 Fortunately, EOS is uncommon but it is an important cause of morbidity and mortality 
in infants, especially in those with VLBW (Tsai et al., 2012) where it was associated 
with a 3 fold increased risk of mortality (Mayor-Lynn et al., 2005).  Nnenna ( Nnenna, 
2012) claimed that, despite diagnostic and therapeutic advances, EOS is associated with 
substantial morbidity and mortality rate of 15%-50%.  
 
The risk factors for EOS in VLBW infants may differ from those found in term infants. 
It is well known that the risk of EOS in newborn is inversely related to gestational age 
and birth weight. In addition to prematurity and low birth weight, several maternal 
factors and intra-partum events, including intra-partum fever, prolonged rupture of 
membranes, chorioamnionitis, maternal GBS colonization, urinary tract infection were 
all identified as risk factors for neonatal sepsis (Chacko and Sohi, 2005; Tsai et al., 
2012). Furthermore, multiparty, multiple courses of prenatal steroids and use of tocolytic 
agents have been found to be associated with EOS in a recent cross sectional study 
(Klinger et al., 2009). 
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The microorganisms most commonly associated with EOS include the following
 
: Group 
B Streptococcus (GBS), Escherichia coli (E.coli), Haemophilus influenza and recently, a 
large study reported on the possible role of Coagulase-negative Staphylococci (CoNS) 
(Paolucci et al., 2012). Group B streptococcus (GBS) was the predominant in the past, 
but the incidence of EOS caused by GBS decreased after the development of guidelines 
for intra-partum antibiotic prophylaxis for GBS infection. This lead to an increased 
incidence of non-GBS pathogens particularly antibiotic resistant E.coli  (Hyde et al., 
2002; Kuhn et al., 2010) 
 
However, in the United States (US) GBS remains an important infectious cause of 
morbidity and mortality among new-born infants, which results in about 1600 cases of 
neonatal sepsis and about 80 deaths annually (Schrag et al., 2002)  The 2007 report 
updates on (GBS) disease in the USA by  the Active Bacterial Core surveillance system 
revealed that, the overall rate of early-onset GBS infection was increased  from 2003 to 
2006, owing to an increasing incidence among black term infants (Apostol et al., 2009). 
 
A study by Al-Taiar aimed to estimate the incidence of neonatal sepsis and determined 
the main causative organisms in few Asian neonatal units. It found that the profile of 
EOS in two (Malaysia and Macau) units seemed to be comparable to that reported 
recently from the USA. The incidence of GBS was low but remained the most frequent 
EOS pathogen. Though, the role of E.coli in these two units appears to be less evident 
(Al-Taiar et al., 2013).  
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1.2.3.1 (B) Late onset sepsis (LOS) 
LOS is commonly defined as sepsis occurring after 48 to 72 hours of birth 
(Chacko and Sohi, 2005; Samanta et al., 2010), suggesting a horizontal transmission of 
the organism. LOS usually occurs as nosocomial (an infection that occurs more than 48 
hours after admission of a baby who on admission did not have evidence of infection) or 
as community-acquired infections. Neonates with LOS mostly present with septicaemia, 
pneumonia or meningitis (Sankar et al., 2008). 
Despite the recent advancement in the neonatal care with considerable improvement of 
survival of preterm infants in general, LOS remains an important cause of mortality and 
morbidity particularly in very low birth weight (VLBW) infants. The incidence of LOS 
and the number of sepsis episodes increases with decreasing birth weight and gestational 
age. Globally, LOS affects around 25% of VLBW infants. In one study among VLBW 
infants, 10.2% had one episode and 2.8% had two episodes while among those with birth 
weight> 2500g, 3.4% had one episode and only 0.7% had two episodes ( Joseph, 2012). 
 
LOS is a serious disease and continues to be a significant cause of morbidity and 
mortality with a mortality rate ranging from 17% to 27% depending on the studied 
population (Lutsar et al., 2011). LOS in premature infants is often secondary to 
prolonged hospital stay and is associated with significant mortality, neurodevelopmental 
impairment among survivors and with increased health care costs (Downey et al., 2010). 
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Like in EOS, Low gestational age and birth weight as a risk factors were highly 
associated with a significant and marked increase in the rate of nosocomial LOS. Other 
risk factors included central line insertion, mechanical ventilation, use and duration of 
total parenteral nutrition (TPN) / lipids and prolonged use of antibiotic usage (Samanta 
et al., 2010).  
 
According to de Brito, central venous catheters are the most important risk factors for 
LOS in NICU patients, particularly in VLBW infants. They found that, moving to a 
temporary NICU with higher admission activity and poor hand washing facilities 
resulted in higher rates of hospital acquired infection ( de Brito et al., 2007).   
Factors that may increase community acquired LOS include poor hygiene, poor cord 
care, bottle feeding and parenteral fluids (Sankar et al., 2008).  
 
The range of organisms causing LOS included Gram-positive, Gram-negative organisms 
and fungal infection with a predominance of bacterial causes (Joseph et al., 2012). 
The predominant organisms in LOS are coagulase negative staphylococci (CoNS), 
accounting for 36-66% of cases, whereas the Gram-negative rods like Klebsiella 
pneumoniae, Escherichia coli, Serratia species and Enterobacter cloacae were 
responsible for about 26-36% of cases. In recent years the incidence of Gram negative 
sepsis appeared to be increasing in many NICUs worldwide (Lutsar et al., 2011). 
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1.2.4 Diagnosis of neonatal sepsis 
 
 
The diagnosis of sepsis neonatorum has generally two phases. The first phase is 
suspected sepsis. Whenever the suspicion of sepsis is strong enough, the start of 
antibiotics is warranted because if the diagnosis of sepsis is missed or delayed, the 
consequence for the baby could be detrimental (Edmond and Zaidi, 2010) 
There are several parameters that will increase the suspicion of sepsis in neonates and 
they can be categorised as risk factors, clinical signs or symptoms and laboratory 
parameters. Each of these will be discussed in some detail below.  
The second phase of the diagnosis of sepsis is when the results of essential 
investigations such as CBC, CPR, as well as the result of blood culture are known.  In 
several studies (Fleming et al., 2012; Griffin et al., 2007), based on these results the 
baby is diagnosed as;  
- Confirmed sepsis in cases where the blood culture is positive with a pathogen 
- Clinical sepsis in cases where the blood culture is negative but other clinical and 
laboratory evidence points strongly to the diagnosis of sepsis 
- No sepsis if the blood culture is negative and subsequent clinical and laboratory 
evidence does not support the diagnosis of sepsis.  
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1.2.4.1 Suspected Sepsis 
1.2.4.1(A) Risk factors (from history) 
Risk factors play an important role in the diagnosis of suspected infection. The 
more risk factors a certain baby has, the lower the threshold for the diagnosis for 
suspected infection tends to be. Generally for term babies, rarely antibiotics are 
recommended to start if there are absolutely no physical signs of infection. However in 
the presence of mild signs of infection, the presence or absence of risk factors may be 
the determining factor to start or not to start antibiotics. One particularly strong risk 
factor for infection is prematurity and for preterm babies with multiple risk factors it 
may, even in the absence of clinical signs be justified to start antibiotics while awaiting 
the results of investigations into the presence of septicaemia. 
 A variety of risk factors are commonly used in several guidelines that are 
available to the medical practitioners (Sarkar et al., 2006; Swarnkar, 2012). These risk 
factors include the gestational age, birth weight, maternal Group B Streptococcal status, 
presence or fever or other signs of infection in the mother, duration between rupture of 
membranes and actual delivery and administration or non-administration of antibiotics 
during the delivery. There is online even one calculator (2014) available that based on 
the presence of the above mentioned risk factors calculates the risk of EOS in babies 
born at or after 34 weeks of gestation. The formulas were derived based on published 
work by Puopolo and Escobar (Puopolo et al., 2011; Escobar et al., 2014) 
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1.2.4.1 (B) Clinical signs (from physical examination) 
The clinical signs that make doctors suspect infection in neonates are often non-
specific. Many of the signs of sepsis can be caused by other common problems in 
neonates such as anaemia, electrolyte disturbances, persistent ductus arteriosus, 
intracranial complications, worsening respiratory distress due to any cause and a variety 
of other problems. Besides a lack of specificity of individual signs and symptoms, there 
tend to be also a lack of sensitivity. Most signs are only present in a fraction of the 
patients with sepsis. The presentation and the early signs of sepsis are quite variable 
among individual babies.  
The above makes research into the diagnosis complex and more difficult. Since 
universal definitions of sepsis are generally lacking, many researchers in the past have 
used different definitions to define clinical sepsis. During clinical practice the decisions 
to continue antibiotics are more leaning towards experience based decisions than 
towards decisions made based on solid evidence. Most clinicians tend to look for 
combinations of risk factors, clinical signs and laboratory parameters to make their bed 
side decisions.  
Clinical parameters that have been used for this purpose and which are incorporated in 
some guidelines on the use of antibiotics in the NICU are collected and listed in tables 
2.1 and 2.2. Some of these parameters are general and do not point to any infection, 
table 2.1 while other parameters tend to point to certain localization which could be the 
port of entry or the major affected organ, table 2.2.  
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Table 2.1 Common non –specific clinical manifestations of neonatal sepsis 
General manifestation 
 Not looking well / Poor cry 
 Lethargy / irritability 
 Refusal to suck 
Metabolic alteration  
 Metabolic acidosis 
 Hypoglycaemia 
 Hyperglycaemia 
 Neonatal jaundice 
Respiratory problems 
 Respiratory distress 
 Apnoea 
Temperature abnormality 
 Hypothermia  
 Hyperthermia 
Heart rate abnormality 
 Bradycardia 
 Tachycardia 
GIT manifestation 
 Vomiting 
 Increased per feed gastric aspirates 
 Abdominal distension 
Neurological manifestation 
 Hypotonia  
 Absent neonatal reflexes 
 Convulsion 
Skin manifestations 
 Mottling  
 Sclerema  
Haematological &Coagulopathy 
 Bleeding 
 petechial, purpura 
 Disseminated Intravascular Coagulation (DlC) 
Cardiovascular:  
 Hypotension, 
 Poor perfusion 
 Prolonged capillary refill time of >3 seconds  
 Shock. 
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Table 2.2 Organ /system related clinical manifestations of neonatal sepsis 
Central nervous system (CNS) 
 Bulging anterior fontanilla 
 Vacant stare  
 High-pitched cry 
 Excess irritability  
 Stupor/ neck retraction 
 
Pneumonia  
 Chesty cough 
 Respiratory distress 
 Chest indrawing 
 Grunting 
 Pneumonic changes in CXR 
 
Gastrointestinal (AGE / NEC) 
 Vomiting/ diarrhoea/ dehydration 
 Feed intolerance /Abdominal distension/Paralytic ileus  
 
Skin infection   
 Multiple pustules 
 Abscess  
 Umbilical stump swelling, redness, foul smelling and discharge. 
 
Osteomyelitis 
 Disability 
 Local swelling or erythema 
 Focal tenderness over a long bone 
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Several studies have been done worldwide aimed to determine the most common 
features associated with neonatal sepsis. 
A study carried out in Bangladesh in 2006, to determine the clinical manifestation 
profile of neonatal sepsis, found that the most common clinical presentations included 
lethargy (73.4%), abdominal distension (70%),  reluctance to feed (96.7%), jaundice 
(50%) and  hypothermia (40%) (Waliullah et al., 2009).To some extent, this was in 
keeping with the results of a study by Kayange , where the inability to feed, lethargy, 
convulsion and cyanosis were found to be significantly associated with positive culture 
in both early and late onset sepsis. Tachypnea was found to be the only predictor of 
positive culture in early onset sepsis. Chest in-drawing, hypothermia, jaundice and 
umbilical redness were significant predictors in late onset sepsis (Kayange et al., 2010). 
Fleming has considered that respiratory distress is most common sign of neonatal 
infection (Fleming et al., 2012). 
 
The results of a Longitudinal Analysis done in Korea by Shim et al indicate that, 
apnoea (19.7%) and fever (19.7%) were the most common symptoms of sepsis followed 
by bradycardia and hyperglycaemia. The study also found  that very preterm infants  
born at less than  32  gestational weeks with sepsis tend to show non specific symptoms 
like apnoea, bradycardia and hyperglycaemia rather than typical signs such as fever 
which found to be the most common symptoms among those who were born beyond 32 
gestational week (Shim et al., 2011). 
In an effort to develop simple algorithms for early detection of serious neonatal illness 
including sepsis, by primary health care workers in developing countries, the Young 
Infants Clinical Signs Study Group recently conducted a large multi-country study to 
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identify clinical signs with high sensitivity and specificity for predicting the requirement 
for new-born referral using senior physician judgment as the gold standard. They 
declared that common clinical signs such as difficulties in feeding, convulsions, 
movement only when stimulated, tachypnoea, severe chest in-drawing, fever 
/hypothermia could be easily identified by health workers in primary care settings and 
indicated a need for referral (Ganatra and Zaidi, 2010). 
 
1.2.4.1 (C) Laboratory parameters 
Many laboratory parameters take some time to come back and will play a role only in 
the later decision to continue or discontinue antibiotics. There is however laboratory 
parameters that are readily available at the bedside or that can be obtained in general 
very fast from the laboratory. Such laboratory parameters may help in the decision on 
whether or not to start antibiotics when other factors that could be pointing to the 
presence of infection are present.  
The blood sugar is commonly done as a bedside test and blood sugar abnormality 
(hypo/ hyperglycaemia) could be one of the factors playing a role in the decision to start 
antibiotics or not. 
Hypoglycaemia is one of the metabolic signs that frequently accompany neonatal sepsis. 
The glucose requirement increased in neonates with septic state.  Low level of  cortisol 
secondary  to inadequate response from the adrenal gland may be the cause of 
hypoglycaemia specially if associated with hypotension (Anderson-Berry et al., 2006). 
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Since long there are reported case series where hypoglycaemia was among the 
prominent presenting signs of neonatal sepsis (Yeung, 1970). 
Hyperglycaemia has been reported as a presenting  sign of bacterial or fungal sepsis, 
especially in extremely low birth weight and preterm babies (Shim et al., 2011; Fanaroff 
et al., 1998).  
Another parameter that is readily available in the wards is the presence or absence of 
metabolic acidosis from the blood gas results (Cloherty et al., 2008). A report by Mathur 
showed that, metabolic acidosis was one of the significant independent predictors of 
mortality in neonatal sepsis (Mathur et al., 1996). Metabolic acidosis noted in many 
neonates with sepsis could explained by the poor tissue oxygenation which resulted in 
anaerobic metabolism with increased the production of lactic acid (Rubarth, 2008).  
 
1.2.4.2 Definite diagnosis 
 
When the results of the blood culture and other laboratory are available, usually 
within 48 hours, a more definite diagnosis is often possible. As stated above, the 
diagnosis of either culture confirmed sepsis, clinical sepsis is made. Below the value of 
individual laboratory parameters is discussed. 
 
In view of the mortality and serious complications associated with neonatal sepsis, the 
most desirable characteristics for an ideal diagnostic test for neonatal sepsis, including 
early onset neonatal sepsis, is a very high sensitivity, rather than high specificity and a 
negative predictive value approaching 100% is wanted (Mishra et al., 2006; Chirico and 
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Loda,2011; Radulova, 2009). Such test is essential to differentiate infected and non 
infected infants and would allow safe withholding of antibiotics in babies at risk of or 
with a specific signs of sepsis (Zuppa et al., 2007). 
 
Numerous tests have been evaluated looking for one that could be helpful in the 
diagnosis, one that rapidly confirms the diagnosis, and another which could rules it out. 
(Tappero and Johnson, 2010). Unfortunately there is no laboratory marker that has all of 
the characteristics of an ideal infection marker (Radulova, 2009). 
 
 Blood cultures remain the gold standard for diagnosis of neonatal sepsis. However, 
most district and community hospitals in developing countries do not possess facilities 
to perform blood cultures, and their reliability for the diagnosis of sepsis in neonatal 
period is still considered a hot topic for discussion.  
 
It may be useful to use serial measurements of different markers of infection to screen 
for sepsis in the symptomatic and asymptomatic infants (Madan et al., 2003). 
 Likewise, the use of multiple markers, in particular, combining an early sensitive 
marker with a late specific test will promote the enhancement of the diagnostic 
accuracy of these mediators to identify infected babies. Serial measurement of such 
markers will certainly improve the diagnostic sensitivity of these tests (Radulova, 
2009).  
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1.2.4.2.1 Blood culture 
  It is the golden standard for diagnosis of sepsis and should be taken in all cases 
of suspected sepsis prior to starting antibiotics. A positive blood culture with 
determination of antibiotic sensitivity of the isolated organism is the best guide to 
antimicrobial therapy (Sankar et al., 2008) 
 
However, neonatal blood cultures present exceptional problems with regards to 
reliability (Døllner et al., 2001).Its sensitivity has long been considered controversial 
with early reports of sensitivity for identifying sepsis being only 50% to 80% (Tappero 
and Johnson, 2010). 
 
Fastidious organisms, maternal intra-partum antibiotic treatment and limited specimen 
volumes were all blamed to decrease the sensitivity of blood cultures. Moreover, 
contamination by skin flora such as CoNS may be another problem (Venkatesh et al., 
2010). Postnatal blood cultures may be sterile (false negative) owing to maternal  
administration of antimicrobial agents during labour as prophylaxis to GBS infections or 
to treat PROM or suspected intra-amniotic infection (Polin et al., 2012). Therefore, a 
negative culture could not exclude sepsis in the new-born (Tappero and Johnson, 2010). 
 
Few and simple but important  steps were recommended to optimize the reliability of 
blood culture in the new-born including: culturing early in the septic episode, applying 
of strict aseptic technique when collecting the specimen in order to  minimize the 
possibility of contamination , collection of adequate volume of blood sample (0.5 - 1.0 
